APA (7th ed.) Citation

CH, H., TY, C., YM, C., SH, L., TN, C., KH, H., & JJ, Y. (2026). Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants. Frontiers in immunology, 17, 1793368. https://doi.org/10.3389/fimmu.2026.1793368

Chicago Style (17th ed.) Citation

CH, Hsu, Chang TY, Chang YM, Lin SH, Chen TN, Hsu KH, and You JJ. "Development of Bispecific Antibodies with Enhanced Neutralization Activity Against Tested SARS-CoV-2 Omicron Subvariants." Frontiers in Immunology 17 (2026): 1793368. https://doi.org/10.3389/fimmu.2026.1793368.

MLA (9th ed.) Citation

CH, Hsu, et al. "Development of Bispecific Antibodies with Enhanced Neutralization Activity Against Tested SARS-CoV-2 Omicron Subvariants." Frontiers in Immunology, vol. 17, 2026, p. 1793368, https://doi.org/10.3389/fimmu.2026.1793368.